Related Experiment Video
Updated: Nov 20, 2025

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
Published on: January 17, 2025
Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study
Sheng Zhong1, Bo Wu2,3, Wenzhuo Yang2
1Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Two natural compounds, ZINC000003938684 and ZINC000014811844, show high binding affinity and favorable safety profiles as potential PARP inhibitors. These findings have implications for designing new CMET target drugs.
Area of Science:
- Computational chemistry
- Drug discovery
- Pharmacology
Background:
- Poly (ADP-ribose) polymerase (PARP) is a key target for various therapeutic interventions.
- Identifying novel inhibitors with high efficacy and safety is crucial for drug development.
Purpose of the Study:
- To screen for ideal lead compounds and drug candidates that inhibit PARP using virtual screening.
- To identify potential PARP inhibitors with favorable safety profiles from the ZINC database.
Main Methods:
- Structure-based virtual screening using LibDock.
- Absorption, Distribution, Metabolism, and Excretion (ADME) and toxicity predictions.
- Molecular docking and molecular dynamics simulations to assess binding affinity and complex stability.
Main Results:
- Two natural compounds, ZINC000003938684 and ZINC000014811844, identified as potent PARP binders with high affinity.
- Predicted favorable safety profiles, including low rodent carcinogenicity, Ames mutagenicity, and developmental toxicity.
- Molecular dynamics simulations confirmed stable interactions between the compounds and PARP.
Conclusions:
- ZINC000003938684 and ZINC000014811844 are promising candidates for PARP inhibitors.
- These compounds exhibit desirable safety characteristics, positioning them as viable drug candidates.
- The findings offer valuable insights for the design and enhancement of CMET target drugs.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:17A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...